Produktname:4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

IUPAC Name:4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

CAS:73183-34-3
Molekulare Formel:C12H24B2O4
Reinheit:98%
Katalognummer:CM104974
Molekulargewicht:253.94

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM104974-1000g in stock ȃŹŹ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:73183-34-3
Molekulare Formel:C12H24B2O4
Schmelzpunkt:-
SMILES-Code:CC1(C)C(C)(C)OB(B2OC(C)(C)C(C)(C)O2)O1
Dichte:
Katalognummer:CM104974
Molekulargewicht:253.94
Siedepunkt:
Mdl-Nr.:MFCD00799570
Lagerung:Keep in a tight container and store at ambient temperature,protect from light

Category Infos

Boronic Acids and Esters
Boronic acids and boronate esters are commonly used reagents in Suzuki–Miyaura coupling chemistry. Organoboron derivatives are common reagents for C–C bond formation, either through classical palladium-mediated transformations or through other newer coupling methods. Boronic esters and acids are potential intermediates in the manufacture of many active pharmaceutical ingredients (API).
Boronic Acid For Sale
Find trusted boronic acid for sale. Any requirements and problems can ask us at any time.
Hydrogen Storage Materials
Hydrogen storage materials are materials which can store and release hydrogen gas. These materials are important for the development of hydrogen fuel cell technology, as they allow for the safe and efficient storage of hydrogen. There are several types of hydrogen storage materials, including: 1. Sorbent Materials. Carbon-based materials such as nanotubes, fullerenes, graphene, mesoporous silica, metal-organic frameworks (MOFs), isoreticular metal-organic frameworks (IRMOFs), covalent-organic frameworks (COFs), and clathrates belong to this category. 2. Complex Hydrides. These consist of light metal hydrides and chemical hydrides. 3. Nanostructured materials. These are composed of functionalized sorbent materials as well as nanoparticles of complex hydrides. The development of efficient and cost-effective hydrogen storage materials is crucial for the widespread adoption of hydrogen fuel cell technology.
Organic Light-Emitting Diode (OLED)
Organic light emitting diodes (devices) or OLEDs are monolithic solid-state devices that typically consist of a series of organic thin films sandwiched between two thin film conductive electrodes. It is a display technology used in many electronic devices, such as smartphones, televisions, and wearables. In an OLED display, each pixel is made up of organic compounds that emit light when an electric current passes through them. Unlike traditional LCD displays, this eliminates the need for a backlight. As a result, OLED displays can achieve deeper blacks and higher contrast ratios, leading to vibrant and more realistic images.
Organic Photodiode (OPD)
The most common type of organic photodetector is the organic photodiode (OPD). The photodiode has a simple structure in which an active layer is sandwiched between a transparent electrode and a metal electrode. In contrast to OLEDs, organic photodiodes (OPDs) utilize the organic semiconductor to absorb incident light and convert it to electric current. The structure and working principle are more like organic solar cells. Among the various organic photodetectors, organic photodiodes (OPDs) have been the most widely studied due to their fast response, high sensitivity, and full use of the existing research base of organic photovoltaics (OPVs).

Column Infos

Fenebrutinib
Roche’s investigational drug, Fenebrutinib has shown brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis (MS) from the recent release of new data from Phase II FENopta study. Fenebrutinib is a potent and highly selective Bruton’s tyrosine kinase (BTK) inhibitor, and currently the only reversible inhibitor being tested in Phase III MS trials. BTK inhibitor is involved in key pathological features of MS, including B-cell development and activation.
CFT7455
C4 Therapeutics recently announces positive results from initial study of CFT7455 in Relapsed/Refractory Multiple Myeloma (R/R MM). CFT7455 is a potent, selective MonoDAC (Monofunctional Degradation Activating Compound) degrader of IKZF1/3 gene. It binds to cereblon (CRBN) E3 ligase with high affinity in Multiple Myeloma and Non-Hodgkin Lymphoma. CFT7455 can act as a single agent or in combination with Dexamethasone for R/R MM patients.
Zegocractin
CalciMedica announces positive topline data from phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP). The trial met primary objective with statistically significant dose response. Calcium release–activated calcium (CRAC) channels are involved in activating T cells, and responsible for regulating calcium-dependent inflammatory pathways or tissue cell injury pathways. AP is a potentially life-threatening inflammatory disease of the pancreas featured by aberrant signaling of calcium.
CalciMedica’s Auxora is a potent and selective intravenous formulated CRAC channel inhibitor containing the active ingredient Zegocractin. It is being developed for the treatment of acute inflammatory and immunologic illnesses, including severe AP, AIPT, AKI, and severe acute respiratory diseases including AHRF, and ARDS. 

Related Products